Skip to content
Spatial Biology & Digital Pathology

From native tissue to quantitative translational insight.

IRBM combines automated multiplex staining, whole-slide imaging, high-plex spatial proteomics, and quantitative digital pathology to reveal where biology happens — across oncology and neuroscience discovery programs.
Native tissue contextSingle-cell quantificationDecision-ready reporting

Representative spatial image

Why spatial tissue analysis

Move beyond whether a marker is present.

Resolve which cells express it, where they sit, who surrounds them, and how that architecture changes with disease or treatment.
◎

Biology in context

Preserve tissue architecture while measuring cell identity, phenotype, and local microenvironment.
⌁

More biology per section

From focused mIF panels to 100+ marker discovery, extract deeper information from limited tissue.
↗

From image to decision

Convert morphology and marker expression into reproducible single-cell, regional, and spatial readouts.
Traditional IHC → Multiplex spatial contextDrag to compare

Multiplex IFTraditional IHC

↔

Traditional IHCMultiplex / spatial

One platform, two depths of interrogation

Choose the spatial depth your question needs.

Focused, hypothesis-driven multiplexing and high-plex discovery sit within the same digital pathology workflow.

Targeted Multiplex IF

Up to 9 biomarkers per section in established mIF workflows
Leica BOND RXAkoya PhenoImager HT
Automated staining on Leica BOND RX
Whole-slide multispectral imaging on PhenoImager HT
Panel optimization for FFPE tissue
Quantitative single-cell and ROI analysis
Ideal for focused biomarker, PD, target-validation and translational studies.

High-Plex Spatial Profiling

100+ biomarkers with PhenoCycler-Fusion
Akoya PhenoCycler-Fusion
Iterative high-plex whole-slide imaging
Single-cell spatial phenotyping at scale
Deep discovery from one tissue section
Customizable protein panels and spatial analysis
Ideal for discovery research, complex biology, and comprehensive spatial profiling.
High-Plex Spatial Dataset • PhenoCycler-Fusion

33 biomarkers. One section. A systems-level view.

Toggle individual channels to reconstruct epithelial, lymphoid, myeloid, vascular, proliferative and checkpoint biology directly within the native tissue architecture.
33protein biomarker channels
plus DAPI nuclear counterstain
Explore all 33 biomarkersSwitch any channel on or off. Marker buttons are grouped by biological program for easier navigation.
15active markers
End-to-end workflow

From tissue section to decision-ready spatial insight.

A controlled workflow that combines assay development, automation, whole-slide imaging, single-cell quantification and spatial biology — with targeted mIF and high-plex options.

Study
report
01
Tissue sectionThe workflow starts from native tissue architecture, preserving the context required for downstream quantitative spatial biology.

Automated staining

Leica BOND RX

Standardized, reproducible staining for IHC and targeted multiplex IF, supporting efficient panel implementation across preclinical studies.

Established mIF workflows • up to 9 biomarkers / section

Leica BOND RX

Whole-slide acquisition

PhenoImager HT

Multispectral whole-slide imaging designed for robust multiplex fluorescence acquisition while retaining tissue architecture and regional context.

PhenoImager HT

High-plex branch

PhenoCycler-Fusion

Extend the same tissue-to-insight workflow into discovery-scale, single-cell spatial profiling when much deeper marker coverage is required.

100+ biomarker spatial profiling • single-cell discovery

PhenoCycler-Fusion

Digital pathology analysis pipeline

From pixels to cell-level biology.

The analysis layer converts multiplex imagery into quantitative, interpretable endpoints — moving from tissue architecture to single-cell phenotypes and spatial systems-level insight.

Tissue segmentation
01 • Architecture

Tissue segmentation

Separate biologically meaningful compartments and define region-specific analysis spaces before cell-level quantification.
Cell segmentation
02 • Single cell

Cell segmentation

Detect nuclei and cell boundaries to create a quantitative single-cell representation of the tissue.
Cell phenotyping
03 • Phenotypes

Cell phenotyping

Classify cell populations from marker combinations and quantify expression within biologically relevant phenotypes.
Spatial systems biology
04 • Spatial insight

Spatial & systems biology

Resolve regional distributions, proximity, neighborhoods and cell-cell relationships to support biological interpretation.
Quantitative endpoints% positive cells, intensity, counts and densities
Cell-type specificityMarker expression resolved by phenotype
Spatial relationshipsProximity, neighborhoods and regional burden
Decision-ready outputFigures, tables, statistics and scientific reporting
Therapeutic focus

Spatial biology in Oncology and Neuroscience.

Two therapeutic areas, one principle: preserve tissue context and convert it into quantitative biological evidence.

Oncology & Immuno-Oncology

Resolve the tumor microenvironment, not just marker positivity.

Quantify tumor architecture, immune infiltration, proliferation, checkpoint biology and treatment-associated spatial changes across preclinical and translational tissue studies.

Tumor microenvironment

Separate tumor, stroma and immune compartments and quantify cell populations within each niche.
PanCKCD3CD8CD68

Pharmacodynamic response

Connect tissue-level pathway modulation and proliferation to treatment groups and in vivo outcomes.
Ki67pERKPD-L1

Immune contexture

Map cytotoxic, regulatory and myeloid populations and their spatial relationships to tumor compartments.
FoxP3PD-1CD45

Target & biomarker validation

Localize target expression by cell type, tissue compartment and disease context before downstream decisions.

Neuroscience & Rare Disease

Map regional pathology and cell-type-specific biology across brain tissue.

Combine neuronal and glial phenotyping with aggregate, intensity and regional readouts to understand disease burden and treatment-associated changes in native CNS architecture.

Regional brain mapping

Quantify cortex, striatum, hippocampus and other defined regions without losing anatomical context.
NeuNDARPP-32

Aggregate burden – case study example

Measure aggregate positivity, number, size and distribution at cell-type and region level.
EM48HTT

Neuroinflammation

Profile glial and neuronal responses while preserving the local CNS microenvironment.
GFAPIba1

Target engagement & PD

Link molecular modulation to anatomically resolved tissue outcomes and disease-relevant cell populations.

Whole-embryo multiplex spatial imaging

Neurodevelopment

Whole-embryo spatial imaging for developmental biology.

Embryonic tissue can be profiled at whole-section scale to reveal regional organization, marker distribution and neurodevelopmental patterns with preserved spatial context.

Whole-embryo mapping

Capture large anatomical context in a single section, from early structural organization to region-level biological patterning.
Whole sectionEmbryoAtlas-style view

Neurodevelopmental marker localization

Visualize lineage, differentiation and developmental programs across brain and peripheral embryonic compartments.
PatterningDifferentiationRegionalization

Single-cell and regional readouts

Move from visually rich morphology to quantitative segmentation, cell phenotyping and region-resolved endpoints.
SegmentationCell statesQuantification

Translational utility

Support developmental neuroscience studies, model characterization and comparative biology with high-content spatial imaging.
Mouse modelsCNS developmentSpatial biology
The IRBM advantage

Digital pathology embedded within drug discovery.

Spatial tissue analysis is most powerful when it is interpreted together with the rest of the biology. IRBM can place tissue-level biomarkers alongside in vivo pharmacology, PK/PD, molecular imaging and translational readouts — within one scientific environment.

Tissue imagingArchitecture + phenotypes
In vivo pharmacologyEfficacy + model biology
PK / PDExposure + response
Translational biomarkersDecision-ready evidence
Quantitative digital pathology

Images are only the beginning.

Analysis plans are customized to the tissue, biological question and decision endpoint.
▦

Tissue segmentation

Define compartments, anatomical regions and ROIs with morphology-aware analysis.
◉

Cell segmentation & phenotyping

Single-cell detection, marker extraction, positivity scoring and phenotype assignment.
⌁

Spatial relationships

Co-localization, nearest-neighbor, proximity and neighborhood analysis.
∑

Quantitative reporting

Cell-level tables, region summaries, figures, spatial maps and scientific interpretation.
↕

Object / aggregate metrics

Size, number, intensity and spatial distribution of disease- or target-related objects.
⌘

Regional analysis

Normalize by area, cells or phenotype within biologically defined tissue regions.
◫

Whole-slide data

Preserve high-resolution context while extracting interpretable quantitative endpoints.
✦

Scientific interpretation

Deliver results as a biological story — not just a spreadsheet of measurements.
Resources

White papers, case studies and technical insight.

A resource section designed to turn the webpage into a scientific entry point — not just a capability list.

Insights from Spatial Biology in Drug Discovery at IRBM

White paper

Insights from Spatial Biology in Drug Discovery at IRBM

The impact of cellular ecosystems, tissue architecture and spatial biomarkers across drug discovery.

Explore white paper →

Ready when you are

Let’s design your spatial biology study.

Tell us the tissue, the biological question and the decision you need to make. We’ll map the right platform, panel and analysis strategy.

Discuss a study →

Back To Top
No results found...